John Ventre

7.9k total citations · 1 hit paper
18 papers, 6.2k citations indexed

About

John Ventre is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, John Ventre has authored 18 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Physiology and 3 papers in Surgery. Recurrent topics in John Ventre's work include Peroxisome Proliferator-Activated Receptors (7 papers), Metabolism, Diabetes, and Cancer (7 papers) and Adipose Tissue and Metabolism (6 papers). John Ventre is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (7 papers), Metabolism, Diabetes, and Cancer (7 papers) and Adipose Tissue and Metabolism (6 papers). John Ventre collaborates with scholars based in United States, United Kingdom and Sweden. John Ventre's co-authors include Thomas W. Doebber, David E. Moller, Margaret Wu, Gaochao Zhou, Michael F. Hirshman, Laurie J. Goodyear, Yuli Chen, Robert P. Myers, Judy Fenyk‐Melody and Nicolas Musi and has published in prestigious journals such as Journal of Clinical Investigation, Diabetes and Endocrinology.

In The Last Decade

John Ventre

18 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of AMP-activated protein kinase in mechanism of metformin action

2001 4.5k citations Gaochao Zhou, Robert P. Myers et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Ventre United States	14	4.3k	1.8k	1.6k	1.5k	1.2k	18	6.2k
Judy Fenyk‐Melody United States	10	3.9k 0.9×	1.7k 0.9×	1.1k 0.7×	1.4k 0.9×	900 0.8×	10	5.5k
Yasuo Akanuma Japan	42	3.8k 0.9×	1.8k 1.0×	1.8k 1.2×	2.1k 1.4×	902 0.8×	143	7.2k
Fabrizio Andréelli France	28	4.7k 1.1×	2.6k 1.5×	2.5k 1.6×	1.7k 1.1×	1.1k 0.9×	88	7.2k
Renee Leboeuf United States	49	2.4k 0.6×	1.7k 1.0×	1.3k 0.9×	1.0k 0.7×	1.1k 0.9×	107	6.5k
Thomas W. Doebber United States	34	6.0k 1.4×	2.1k 1.2×	2.4k 1.5×	1.9k 1.2×	1.6k 1.4×	58	9.1k
Mengwei Zang United States	30	3.3k 0.8×	986 0.6×	1.6k 1.0×	1.1k 0.7×	1.7k 1.5×	42	6.1k
H. Henry Dong United States	39	3.5k 0.8×	1.6k 0.9×	1.3k 0.8×	1.3k 0.8×	1.0k 0.9×	71	5.9k
Nobuharu Fujii Japan	3	3.7k 0.8×	1.6k 0.9×	1.0k 0.6×	1.4k 0.9×	851 0.7×	7	4.9k
Anne Tailleux France	40	2.4k 0.6×	1.7k 1.0×	1.2k 0.8×	1.4k 0.9×	1.9k 1.6×	100	6.0k
Sotirios K. Karathanasis United States	42	3.1k 0.7×	2.1k 1.2×	831 0.5×	1.5k 1.0×	639 0.5×	85	6.2k

Countries citing papers authored by John Ventre

Since Specialization

Citations

This map shows the geographic impact of John Ventre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Ventre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Ventre more than expected).

Fields of papers citing papers by John Ventre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Ventre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Ventre. The network helps show where John Ventre may publish in the future.

Co-authorship network of co-authors of John Ventre

This figure shows the co-authorship network connecting the top 25 collaborators of John Ventre. A scholar is included among the top collaborators of John Ventre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Ventre. John Ventre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Berger, Joel P., Ann Petro, Karen L. MacNaul, et al.. (2003). Distinct Properties and Advantages of a Novel Peroxisome Proliferator-Activated Protein γ Selective Modulator. Molecular Endocrinology. 17(4). 662–676. 271 indexed citations

2.

Zhou, Gaochao, Robert P. Myers, Ying Li, et al.. (2001). Role of AMP-activated protein kinase in mechanism of metformin action. Journal of Clinical Investigation. 108(8). 1167–1174. 406 indexed citations

3.

Zhou, Gaochao, Robert P. Myers, Ying Li, et al.. (2001). Role of AMP-activated protein kinase in mechanism of metformin action. Journal of Clinical Investigation. 108(8). 1167–1174. 4500 indexed citations breakdown →

4.

Losco, Patricia E., et al.. (2001). Comparison of the effects of radiographic contrast media on dehydration and filterability of red blood cells from donors homozygous for hemoglobin A or hemoglobin S. American Journal of Hematology. 68(3). 149–158. 35 indexed citations

5.

Wang, Pei-Ran, Qiu Guo, Marc C. Ippolito, et al.. (2001). High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists. European Journal of Pharmacology. 427(3). 285–293. 51 indexed citations

6.

DeLuca, John G., Thomas W. Doebber, Linda J Kelly, et al.. (2000). Evidence for Peroxisome Proliferator-Activated Receptor (PPAR)α-Independent Peroxisome Proliferation: Effects of PPARγ/δ-Specific Agonists in PPARα-Null Mice. Molecular Pharmacology. 58(3). 470–476. 46 indexed citations

7.

DeLuca, John G., Thomas W. Doebber, Linda J Kelly, et al.. (2000). Evidence for Peroxisome Proliferator-Activated Receptor (PPAR)α-Independent Peroxisome Proliferation: Effects of PPARγ/δ-Specific Agonists in PPARα-Null Mice. Molecular Pharmacology. 58(3). 470–476. 2 indexed citations

8.

Kelly, Linda, Pasquale P. Vicario, G M Thompson, et al.. (1998). Peroxisome Proliferator-Activated Receptors γ and α Mediate in Vivo Regulation of Uncoupling Protein (UCP-1, UCP-2, UCP-3) Gene Expression. Endocrinology. 139(12). 4920–4927. 245 indexed citations

9.

Zierath, Juleen R., Jeffrey W. Ryder, Thomas W. Doebber, et al.. (1998). Role of Skeletal Muscle in Thiazolidinedione Insulin Sensitizer (PPARγ Agonist) Action. Endocrinology. 139(12). 5034–5041. 118 indexed citations

10.

Fairweather, William R., Ludwig A. Hothorn, Ralph L. Kodell, et al.. (1998). Biostatistical Methodology in Carcinogenicity Studies. Drug Information Journal. 32(2). 401–421. 15 indexed citations

11.

Ventre, John, Thomas W. Doebber, Margaret Wu, et al.. (1997). Targeted Disruption of the Tumor Necrosis Factor-α Gene: Metabolic Consequences in Obese and Nonobese Mice. Diabetes. 46(9). 1526–1531. 239 indexed citations

12.

Berger, N., Chhabi Biswas, D. Neil Hayes, et al.. (1996). An antidiabetic thiazolidinedione potentiates insulin stimulation of glycogen synthase in rat adipose tissues.. Endocrinology. 137(5). 1984–1990. 24 indexed citations

13.

Bugelski, Peter J., et al.. (1995). Ultrastructural Evidence of an Interaction between Env and Gag Proteins during Assembly of HIV Type 1. AIDS Research and Human Retroviruses. 11(1). 55–64. 27 indexed citations

14.

Hart, T K, et al.. (1993). Morphometric analysis of envelope glycoprotein gp120 distribution on HIV-1 virions.. Journal of Histochemistry & Cytochemistry. 41(2). 265–271. 16 indexed citations

15.

Sparrow, Carl P., Thomas W. Doebber, Jurek Olszewski, et al.. (1992). Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine.. Journal of Clinical Investigation. 89(6). 1885–1891. 172 indexed citations

16.

Griswold, Don E., et al.. (1991). Technique for quantification of LTB4-lnduced changes in peripheral granulocyte counts in vivo in the rabbit. Journal of Pharmacological Methods. 25(4). 319–328. 3 indexed citations

17.

Schwartz, Lester W., et al.. (1991). Comparative Biochemical and Morphometric Changes Associated with Induction of the Hepatic Mixed Function Oxidase System in the Rat. Toxicologic Pathology. 19(2). 115–122. 12 indexed citations

18.

Wier, Patrick J. & John Ventre. (1990). Statistical Analyses of Reproductive and Developmental Toxicology Studies. Drug Information Journal. 24(2). 395–405. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact